44881
Terbium Standard für ICP
TraceCERT®, 1 g/L Tb in nitric acid (nominal concentration)
Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise
Alle Fotos(1)
About This Item
Empfohlene Produkte
Qualität
certified reference material
TraceCERT®
Qualitätsniveau
Produktlinie
TraceCERT®
Konzentration
1 g/L Tb in nitric acid (nominal concentration)
Methode(n)
ICP: suitable
Anwendung(en)
industrial qc
pharmaceutical
Format
single component solution
Allgemeine Beschreibung
This certified reference material (CRM) is produced and certified in accordance with ISO/IEC 17025 and ISO 17034.This CRM is traceable to SI unit kg and measured against primary material from an NMI, e.g. NIST.
Certified content incl. uncertainty and expiry date are given on the certificate. Information about trace impurities are stated on the certificate.
Download your certificate at: http://www.sigma-aldrich.com.
Certified content incl. uncertainty and expiry date are given on the certificate. Information about trace impurities are stated on the certificate.
Download your certificate at: http://www.sigma-aldrich.com.
Hinweis zur Analyse
1000 mg/L Tb in 2% Salpetersäure, hergestellt aus hochreinem Tb4O7, HNO3 und Wasser
Sonstige Hinweise
For a complete product listing of our TraceCERT range of CRMs for ICP and AAS, technical information and example certificates please visit our inorganic TraceCERT website
Rechtliche Hinweise
TraceCERT is a registered trademark of Merck KGaA, Darmstadt, Germany
Signalwort
Warning
H-Sätze
Gefahreneinstufungen
Eye Irrit. 2 - Met. Corr. 1 - Skin Irrit. 2
Lagerklassenschlüssel
8B - Non-combustible corrosive hazardous materials
WGK
WGK 1
Flammpunkt (°F)
Not applicable
Flammpunkt (°C)
Not applicable
Choose from one of the most recent versions:
Besitzen Sie dieses Produkt bereits?
In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.
Kunden haben sich ebenfalls angesehen
Immunity, 48(4), 799-811 (2018-04-19)
Epstein-Barr virus (EBV) is a causative agent of infectious mononucleosis and is associated with 200,000 new cases of cancer and 140,000 deaths annually. Subunit vaccines against this pathogen have focused on the gp350 glycoprotein and remain unsuccessful. We isolated human
Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..
Setzen Sie sich mit dem technischen Dienst in Verbindung.